Early research (Phase 1)WithdrawnNCT07297160What this trial is testingCD70.CAR for CD70+ Lymphoma, Myeloma and Solid TumorsWho this might be right forLymphomaMyelomaSolid Tumors+2 more Baylor College of Medicine
Not applicableUnknownNCT05426317What this trial is testingExploratory Interventional Study of Prognostic Serum Biomarkers of Cancer ProgressionWho this might be right forMelanomaNon Small Cell Lung CancerRenal Cancer University Hospital, Clermont-Ferrand 100
Not applicableEnded earlyNCT02439008What this trial is testingEarly Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune ResponseWho this might be right forCarcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more Centre Oscar Lambret 28
Not applicableStudy completedNCT04873180What this trial is testingSignificance of Immunohistochemical Expression of Survivin in Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Sohag University 40
Post-approval studies (Phase 4)Ended earlyNCT00352859What this trial is testingPhase IV Randomization to On-Going Treatment to Evaluate Sustained SorafenibWho this might be right forCarcinoma, Renal Cell Bayer 2
Testing effectiveness (Phase 2)Ended earlyNCT02782715What this trial is testingMicrowave Ablation With MRI-Guided SBRT Boost in Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell University of Wisconsin, Madison 3
Early research (Phase 1)Ended earlyNCT02608125What this trial is testingA Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial CarcinomaWho this might be right forSolid TumorsMetastatic Urothelial Carcinoma & Renal Pelvis & Ureter Principia Biopharma, a Sanofi Company 45
Early research (Phase 1)Ended earlyNCT02410174What this trial is testingTo Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma TumorsWho this might be right forPrimary TumorRenal Cell Carcinoma Beth Israel Medical Center 3
Large-scale testing (Phase 3)Active Not RecruitingNCT01224288What this trial is testingDynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) ScrambleWho this might be right forRenal Cell Carcinoma M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT01551030What this trial is testingBuparlisib in Metastatic Transitional Cell Carcinoma of the UrotheliumWho this might be right forMetastatic Transitional Cell Carcinoma of the Urothelium Memorial Sloan Kettering Cancer Center 19
Not applicableEnrolling By InvitationNCT07046832What this trial is testingClinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue BiopsyWho this might be right forOncologyInterventional RadiologyLiver Carcinoma+2 more MediView XR, Inc. 104
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Early research (Phase 1)Active Not RecruitingNCT03212404What this trial is testingPhase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersWho this might be right forLung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more Checkpoint Therapeutics, Inc. 272
Testing effectiveness (Phase 2)Looking for participantsNCT04895709What this trial is testingBMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsWho this might be right forCervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more Bristol-Myers Squibb 1,109
Not applicableActive Not RecruitingNCT06745609What this trial is testingPrehabilitation Prior to Surgery for Kidney TumorsWho this might be right forRenal CancerRenal Cell CancerKidney Cancers+3 more Herlev and Gentofte Hospital 60
Not applicableStudy completedNCT05410509What this trial is testing"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"Who this might be right forRenal Cell Carcinoma (RCC) University of Alabama at Birmingham 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Not applicableStudy completedNCT00743236What this trial is testingWarm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney CancerWho this might be right forKidney CancerLong-term Effects Secondary to Cancer Therapy in AdultsPerioperative/Postoperative Complications+1 more Wake Forest University Health Sciences 1
Not applicableNot Yet RecruitingNCT07480044What this trial is testingA Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological SurgeryWho this might be right forPostoperative Delirium (POD)Prostate CancerKidney Tumor Zhejiang University 220
Early research (Phase 1)Study completedNCT01183663What this trial is testingLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)Who this might be right forAdvanced Cancers M.D. Anderson Cancer Center 180